Nouveau plaidoyer pour les nouveaux vaccins contre le virus respiratoire syncytial (VRS), dont l’impact, depuis leur introduction l'année dernière, est très surveillé. Cette nouvelle étude, menée par ...

Ces premiers résultats de la cohorte ECHO, soutenue par les US National Institutes of Health (NIH), confirment la relation entre le microbiome intestinal du nourrisson et les traits liés à l'autisme i ...

Cette nouvelle approche, développée par ces biologistes de l’Albert Einstein College of Medicine (Bronx, NY) pourrait améliorer l'efficacité des greffes de cellules souches, aujourd’hui couramment uti ...

2024 ThinkEquity Conference Date: October 30, 2024 Location: New York, NY Format: Company Presentation Time: 10:30 a.m. ET BIO-Europe 2024 Date: November 5, 2024 Location: Stockholm, Sweden Format: ...

CAMPBELL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- VIVUS announced today that the U.S. Food and Drug Administration has removed the requirement for a cardiovascular outcome trial for its ...

The CardiAMP HF Trial is assessing the safety and effectiveness of the CardiAMP ® Cell Therapy System for HFrEF, with the potential to reduce all cause death, future hospitalizations, enhance ...

Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced the successful completion of its acquisition of Dermavant ...

FREDERICK, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI” or the “Company”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination, ...

Lim, MD, PhD, CEO of Medicovestor, Inc. “Our platform not only functionally enhances tumor antigen density but also enables multiple mechanisms for tumor cell destruction. The backbone antibodies ...

(TSXV: CNVI) (“Conavi Medical”), a commercial stage company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is ...

SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of ...

Mr. McDonnell, who has served in his current role since August 2020, has been instrumental to repositioning Biogen towards the goal of returning to sustainable growth. He notably led a program to ...